Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections

Details for Australian Patent Application No. 2009305203 (hide)

Owner AstraZeneca AB

Inventors Barvian, Kevin; Basarab, Gregory Steven; Gowravaram, Madhusudhan Reddy; Hauck, Sheila Irene; Zhou, Fei

Agent Davies Collison Cave

Pub. Number AU-A-2009305203

PCT Pub. Number WO2010/043893

Priority 61/105,189 14.10.08 US

Filing date 13 October 2009

Wipo publication date 22 April 2010

International Classifications

C07D 471/22 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 498/22 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/22 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

24 March 2011 PCT application entered the National Phase

  PCT publication WO2010/043893 Priority application(s): WO2010/043893

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009305211-Separation method

2009305200-Plastics container